John A Bell

AM, BPharm, FPS, Graduate School of Health, University of Technology Sydney, NSW.

Related

There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19. (Image: AAP)

Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine

Off-label prescribing of hydroxychloroquine – or the closely related chloroquine – for prophylaxis of COVID-19 raises a number of potential concerns.